SCHEMBL7300158

SCHEMBL7300158

CC(C)[C@H](NC(=O)OCc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cccnc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.62
CYP3A4 P08684 9/20 0.53
MEN1 O00255 1/20 0.53
SLC22A2 O15244 1/20 0.53
SLC22A1 O15245 1/20 0.53
ABCC3 O15438 1/20 0.53
ABCC4 O15439 1/20 0.53
MLNR O43193 1/20 0.53
NR1I2 O75469 1/20 0.53
SLCO2B1 O94956 1/20 0.53
ABCB11 O95342 1/20 0.53
ALDH1A1 P00352 1/20 0.53
PGR P06401 1/20 0.53
ABCB1 P08183 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CYP2D6 P10635 1/20 0.53
MAPT P10636 1/20 0.53
CHRM1 P11229 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2771252 0.97 CA2 (0.62) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL13240259 0.97 CA2 (0.62) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7310312 0.94 CA2 (0.62) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7298935 0.93 CYP3A4 (0.56) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7307582 0.93 CA2 (0.53) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7303607 0.92 CA2 (0.72) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7301328 0.91 CA2 (0.77) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7431901 0.91 CA2 (0.77) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL7302088 0.91 CA2 (0.62) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL6362507 0.90 CA2 (0.67) CA2CYP3A4MEN1SLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP claimed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP claimed
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed